🇺🇸 FDA
Patent

US 6124262

Compositions and methods for reducing adhesiveness of defective red blood cells

expired A61KA61K38/00

Quick answer

US patent 6124262 (Compositions and methods for reducing adhesiveness of defective red blood cells) held by The Regents of the University of California expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00